skip navigation

Denise M. Boudreau, PhD
Assistant Investigator

Dr. Boudreau is a research scientist with United BioSource Corporation’s Center for Health Economics, Epidemiology, and Science Policy. She will be actively involved in the “Commonly Used Medications and Breast Cancer Recurrence” grant as an assistant scientific investigator at the Group Health Center for Health Studies through September 2012.

Recent Publications:
Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008;17(3):240-7. Epub Jan 16. Abstract

Bonomi AE, Boudreau DM, Fishman PA, Ludman E, Mohelnitzky A, Cannon EA, Seger D. Quality of life valuations of mammography screening.  Qual Life Res. 2008 May 20; [Epub ahead of print]. Abstract

Boudreau DM, Yu O, Buist DS, Miglioretti DL. Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control. 2008; [Epub ahead of print]. Abstract

Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521-7. Abstract

2007
Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194.e1-5. Epub 2007 Oct 1. Abstract

Boudreau DM, Luce CL, Ludman E, Bonomi AE, Fishman PA. Concordance of population-based estimates of mammography screening. Prev Med. 2007;45(4):262-6. Epub 2007 Jul 17. Abstract

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR. Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev. 2007;16(3):416-21. Abstract

Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007;16(12):1275-84 .Epub 2007 Oct 22. Abstract

Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat. 2007; [Epub ahead of print]. Abstract

Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007;45(10 Supl 2):S29-37. Abstract

2006
Boudreau DM, Buist DS, Rutter CM, Fishman PA, Beverly KR, Taplin S. Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography. Med Care. 2006;44(1):62-9. Abstract

Boudreau DM, Rutter CM, Buist DS. The influence of statin use on breast density. Cancer Epidemiol Biomarkers Prev. 2006;15(5):1026-9. Abstract

2005
Bonomi AE, Boudreau DM, Fishman PA, Meenan RT, Revicki DA. Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis. Qual Life Res. 2005;14(4):1127-33. Abstract

Boudreau DM, Doescher MP, Saver BG, Jackson JE, Fishman PA. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiol Drug Saf. 2005;14(12):877-84. Epub 2005 Jun 1. Abstract

Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Res Treat. 2006;95(2):131-40. Epub 2005 Dec 2. Abstract

Greene SM, Larson EB, Boudreau DM, Johnson K, Ralston J, Reid R, Fishman P. The Coordinated Clinical Studies Network: a multidisciplinary alliance to facilitate research and improve care. The Permanente Journal. 2005;95(4):33-5.

Voigt LF, Boudreau DM, Weiss NS, Malone KE, Li CI, Daling JR. Re: "studies with low response proportions may be less biased than studies with high response proportions." Am J Epidemiol. 2005;161(4):401-2. Details

Top